CONTEXT: Activation of the unfolded protein response (UPR) is emerging as an important molecular signature of cardiometabolic diseases associated with obesity. However, despite the well-established role of the vascular endothelium in obesity-related cardiometabolic dysfunction, it is unclear whether the UPR is activated in endothelial cells of obese adults. OBJECTIVE: The objective of the study was to determine whether markers of UPR activation are increased in endothelial cells (ECs) of nondiabetic obese adults with impaired endothelial function. DESIGN, SETTING, AND PARTICIPANTS: Endothelial cells were obtained from antecubital veins of the nondiabetic obese adults [body mass index (BMI) ≥ 30 kg/m(2), n = 12] with impaired endothelial function and from their nonobese peers (BMI < 30 kg/m(2), n = 14). MAIN OUTCOME VARIABLES: UPR activation via expression (quantitative immunofluorescence) of the proximal UPR sensors, inositol-requiring endoplasmic reticulum (ER)-to-nucleus signaling protein 1 (IRE1), RNA-dependent protein kinase-like ER eukaryotic initiation factor-2α kinase (PERK), and activating transcription factor 6 (ATF6), were the main outcome variables. RESULTS: IRE1 expression was greater in obese vs nonobese individuals (0.84 ± 0.09 vs 0.47 ± 0.02 IRE1 intensity/human umbilical vein EC (HUVEC) intensity (n = 10/8, P < .01). Obese individuals also had greater EC activation of UPR stress sensors PERK and ATF6, indicated by increased expression of phosphorylated PERK [p-PERK; 0.49 ± 0.05 vs 0.36 ± 0.03, p-PERK (threonine 981) intensity/HUVEC intensity, n = 10 men, 13 women, P < .05] and nuclear localization of ATF6 (0.38 ± 0.05 vs 0.23 ± 0.02, nuclear ATF6 intensity/HUVEC intensity, n = 5 men, 9 women, P < .01), respectively. Stepwise linear regression analysis revealed that indices of body fat (BMI and waist circumference) were the strongest independent predictors of all 3 UPR mediators, explaining between 18% and 59% of the variance in endothelial cell expression of IRE1, p-PERK, and nuclear ATF6 localization. CONCLUSION: These results provide novel evidence for UPR activation in the endothelial cells of nondiabetic obese adults with vascular endothelial dysfunction.
CONTEXT: Activation of the unfolded protein response (UPR) is emerging as an important molecular signature of cardiometabolic diseases associated with obesity. However, despite the well-established role of the vascular endothelium in obesity-related cardiometabolic dysfunction, it is unclear whether the UPR is activated in endothelial cells of obese adults. OBJECTIVE: The objective of the study was to determine whether markers of UPR activation are increased in endothelial cells (ECs) of nondiabetic obese adults with impaired endothelial function. DESIGN, SETTING, AND PARTICIPANTS: Endothelial cells were obtained from antecubital veins of the nondiabetic obese adults [body mass index (BMI) ≥ 30 kg/m(2), n = 12] with impaired endothelial function and from their nonobese peers (BMI < 30 kg/m(2), n = 14). MAIN OUTCOME VARIABLES: UPR activation via expression (quantitative immunofluorescence) of the proximal UPR sensors, inositol-requiring endoplasmic reticulum (ER)-to-nucleus signaling protein 1 (IRE1), RNA-dependent protein kinase-like ER eukaryotic initiation factor-2α kinase (PERK), and activating transcription factor 6 (ATF6), were the main outcome variables. RESULTS:IRE1 expression was greater in obese vs nonobese individuals (0.84 ± 0.09 vs 0.47 ± 0.02 IRE1 intensity/human umbilical vein EC (HUVEC) intensity (n = 10/8, P < .01). Obese individuals also had greater EC activation of UPR stress sensors PERK and ATF6, indicated by increased expression of phosphorylated PERK [p-PERK; 0.49 ± 0.05 vs 0.36 ± 0.03, p-PERK (threonine 981) intensity/HUVEC intensity, n = 10 men, 13 women, P < .05] and nuclear localization of ATF6 (0.38 ± 0.05 vs 0.23 ± 0.02, nuclear ATF6 intensity/HUVEC intensity, n = 5 men, 9 women, P < .01), respectively. Stepwise linear regression analysis revealed that indices of body fat (BMI and waist circumference) were the strongest independent predictors of all 3 UPR mediators, explaining between 18% and 59% of the variance in endothelial cell expression of IRE1, p-PERK, and nuclear ATF6 localization. CONCLUSION: These results provide novel evidence for UPR activation in the endothelial cells of nondiabetic obese adults with vascular endothelial dysfunction.
Authors: Mete Civelek; Elisabetta Manduchi; Rebecca J Riley; Christian J Stoeckert; Peter F Davies Journal: Circ Res Date: 2009-08-06 Impact factor: 17.367
Authors: Swapan K Das; Winston S Chu; Ashis K Mondal; Neeraj K Sharma; Philip A Kern; Neda Rasouli; Steven C Elbein Journal: Am J Physiol Endocrinol Metab Date: 2008-06-10 Impact factor: 4.310
Authors: Suneng Fu; Abdullah Yalcin; Grace Y Lee; Ping Li; Jason Fan; Ana Paula Arruda; Benedicte M Pers; Mustafa Yilmaz; Kosei Eguchi; Gökhan S Hotamisligil Journal: Sci Transl Med Date: 2015-06-17 Impact factor: 17.956
Authors: Emmanouil Tampakakis; Corey E Tabit; Monika Holbrook; Erika A Linder; Brittany D Berk; Alissa A Frame; Rosa Bretón-Romero; Jessica L Fetterman; Noyan Gokce; Joseph A Vita; Naomi M Hamburg Journal: J Am Heart Assoc Date: 2016-01-11 Impact factor: 5.501
Authors: Natalia Di Pietro; M Loredana Marcovecchio; Sara Di Silvestre; Tommaso de Giorgis; Vincenzo Giuseppe Pio Cordone; Paola Lanuti; Francesco Chiarelli; Giuseppina Bologna; Angelika Mohn; Assunta Pandolfi Journal: Mol Cell Endocrinol Date: 2017-01-03 Impact factor: 4.102
Authors: Stephanie M Cicalese; Josiane Fernandes da Silva; Fernanda Priviero; R Clinton Webb; Satoru Eguchi; Rita C Tostes Journal: Circ Res Date: 2021-04-01 Impact factor: 17.367
Authors: Pablo J Sáez; Roberto Villalobos-Labra; Francisco Westermeier; Luis Sobrevia; Marcelo Farías-Jofré Journal: Front Pharmacol Date: 2014-08-19 Impact factor: 5.810
Authors: Rosa Bretón-Romero; Robert M Weisbrod; Bihua Feng; Monika Holbrook; Darae Ko; Mary M Stathos; Ji-Yao Zhang; Jessica L Fetterman; Naomi M Hamburg Journal: J Am Heart Assoc Date: 2018-09-18 Impact factor: 5.501